Marché mondial du traitement de l'ichtyose acquise - Tendances et prévisions de l'industrie jusqu'en 2028

Analyse et perspectives du marché : marché mondial du traitement de l'ichtyose acquise

Le marché du traitement de l'ichtyose acquise devrait connaître une croissance du marché au cours de la période de prévision 2021-2028. Data Bridge Market Research analyse le marché pour s'attendre à une croissance à un TCAC de 4,50 % au cours de la période de prévision mentionnée ci-dessus.

L'ichtyose acquise est une maladie cutanée rare et non héréditaire qui provoque une peau sèche et rugueuse avec des squames proéminentes en forme de plaques. Elle est également connue sous le nom de peau en écailles de poisson et se développe principalement à l'âge adulte. Elle est associée à différentes maladies, notamment le cancer , la lèpre, les maladies thyroïdiennes, la sarcoïdose, l'hyperparathyroïdie, l'insuffisance rénale chronique, l'infection par le VIH, les troubles nutritionnels et les maladies auto-immunes. Elle survient également comme effet secondaire de certains médicaments. 

L'augmentation de la prévalence de l'ichtyose acquise et la hausse de l'incidence du cancer, de l'infection par le VIH, des maladies auto-immunes, des troubles thyroïdiens et nutritionnels sont les principaux moteurs de ce marché qui stimuleront la croissance du marché. De plus, l'augmentation des dépenses de santé, le développement d'options de traitement, l'augmentation du financement gouvernemental et l'augmentation de l'utilisation de médicaments impliqués dans la thérapie ciblée contre le cancer, par exemple les inhibiteurs de la protéine kinase et le vemurafenib, accéléreront la croissance du marché du traitement de l'ichtyose acquise.

L’augmentation des activités de recherche et développement et l’augmentation du nombre d’essais cliniques offriront des opportunités bénéfiques pour le marché du traitement de l’ichtyose acquise au cours de la période de prévision 2021-2028.

• D'autre part, le coût élevé du traitement et le manque de sensibilisation aux maladies rares constitueront un facteur de restriction et entraveront la croissance du marché. Les complications liées à l'ichtyose acquise, telles que les troubles de l'audition et de la vue, la surchauffe et les infections secondaires, constitueront un défi pour le marché du traitement de l'ichtyose acquise au cours de la période de prévision mentionnée ci-dessus.

This acquired ichthyosis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the acquired ichthyosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Acquired Ichthyosis Treatment Market Scope and Market Size

The acquired ichthyosis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the acquired ichthyosis treatment market is segmented into antibiotic, retinoid, alpha-hydroxy acid lotions, vitamin D supplements, and others.
• On the basis of diagnosis, the acquired ichthyosis treatment market is segmented into skin biopsy, CT scan, physical examination and others.
• On the basis of dosage, the acquired ichthyosis treatment market is segmented into tablet, cream, lotion, ointment and others.
• On the basis of route of administration, the acquired ichthyosis treatment market is segmented into oral, tropical and others.
• On the basis of symptoms, the acquired ichthyosis treatment market is segmented into dry skin, scaly scalp, hyperkeratosis, symmetrical scaling of the skin, keratosis pilaris and others.
• On the basis of end-users, the acquired ichthyosis treatment market is segmented into clinic, hospital and others.

The acquired ichthyosis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Acquired Ichthyosis Treatment Market Country Level Analysis

Acquired ichthyosis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.

The countries covered in the acquired ichthyosis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the acquired ichthyosis treatment market due to the presence of major key players, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, improving healthcare infrastructure and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Acquired ichthyosis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Acquired Ichthyosis Treatment Market Share Analysis

Acquired ichthyosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to acquired ichthyosis treatment market research.

Français Les principaux acteurs couverts dans le rapport sur le marché du traitement de l'ichtyose acquise sont Ion Labs Inc., Bausch Health Companies Inc., Allergan, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Abbott, F. Hoffmann-La Roche Ltd., Mylan NV, Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Lilly, Aurobindo Pharma, Lupin, SHIONOGI & Co., Ltd., AbbVie Inc., Dow, BASF SE, Nabriva Therapeutics plc, Spero Therapeutics et Merck KGaA, entre autres acteurs nationaux et mondiaux. Les données sur les parts de marché sont disponibles séparément pour le monde, l'Amérique du Nord, l'Europe, l'Asie-Pacifique (APAC), le Moyen-Orient et l'Afrique (MEA) et l'Amérique du Sud. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.

SKU-66655